uspto-grants-2012_08 · 10.6084/m9.figshare.5104873.v1 · US08242104B2
查看IDENTITY
结构与身份
- 标准SMILES
- Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1
- InChIKey
- BEUQXVWXFDOSAQ-UHFFFAOYSA-N
- 分子式
- C24H28N8O2
- 平均分子量
- 460.5 g/mol
- 单同位素质量
- 460.23352217
COMPUTED
结构计算性质
- XLogP
- 1.8
- 极性表面积
- 119 Ų
- 氢键供体
- 1
- 氢键受体
- 6
- 可旋转键
- 5
- 重原子
- 34
- 形式电荷
- 0
- 复杂度
- 750
ALIASES
名称与别名
Taselisib1282512-48-4GDC-00322-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamideGDC0032RG-7604L08J2O299MDTXSID001558421H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-alpha,alpha-dimethyl-2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO(F)IMIDAZO(1,2-D)(1,4)OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDEtaselisibum1H-PYRAZOLE-1-ACETAMIDE, 4-(5,6-DIHYDRO-2-(3-METHYL-1-(1-METHYLETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)-ALPHA,ALPHA-DIMETHYL-RefChem:891186DTXCID9078333RO55373812-methyl-2-(4-(4-(3-methyl-1-(propan-2-yl)-1H-1,2,4-triazol-5-yl)-9-oxa-3,6-diazatricyclo(8.4.0.0^(2,6))tetradeca-1(14),2,4,10,12-pentaen-12-yl)-1H-pyrazol-1-yl)propanamideGDC 0032Taselisib [INN]Taselisib (GDC0032)MFCD26142641
REACTIONS
参与反应
uspto-grants-2015_12 · 10.6084/m9.figshare.5104873.v1 · US09198918B2
查看uspto-grants-2014_07 · 10.6084/m9.figshare.5104873.v1 · US08785626B2
查看uspto-grants-2013_01 · 10.6084/m9.figshare.5104873.v1 · US08343955B2
查看uspto-grants-2013_11 · 10.6084/m9.figshare.5104873.v1 · US08586574B2
查看Training data from https://doi.org/10.1039/C8SC04228D (4/10) · 10.1039/C8SC04228D
查看Training data from https://doi.org/10.1039/C8SC04228D (10/10) · 10.1039/C8SC04228D
查看